Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 18/20 | 0.69 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437899 | 1.00 | AGTR2 (0.69) | AGTR2AGTR1CYP3A4CYP2C9CYP2B6 | |
| Trifluoroacetic Acid SCHEMBL25297677 | 0.96 | AGTR2 (0.64) | AGTR2AGTR1CYP3A4 | |
| SCHEMBL29047325 | 0.95 | AGTR2 (0.69) | AGTR2AGTR1CYP2C9CYP2B6 | |
| SCHEMBL29437915 | 0.95 | AGTR2 (0.69) | AGTR2AGTR1CYP2C9CYP2B6 | |
| SCHEMBL29437897 | 0.94 | AGTR2 (0.64) | AGTR2CYP3A4 | |
| SCHEMBL29047268 | 0.94 | AGTR2 (0.64) | AGTR2CYP3A4 | |
| SCHEMBL29437891 | 0.93 | AGTR2 (0.80) | AGTR2AGTR1CYP2C9CYP2B6 | |
| SCHEMBL29047304 | 0.93 | AGTR2 (0.65) | AGTR2AGTR1CYP3A4CYP2C9CYP2B6 | |
| SCHEMBL29047345 | 0.93 | AGTR2 (0.63) | AGTR2AGTR1CYP3A4 | |
| SCHEMBL29437901 | 0.93 | AGTR2 (0.70) | AGTR2AGTR1CYP2C9CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116568682-A | Novel compounds for the treatment of angiotensin II related diseases | 维科尔药物公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116568682-A | Novel compounds for the treatment of angiotensin II related diseases | 维科尔药物公司 | 2023-08-08 | — | — | CN | disclosed |